DataM Intelligence 4 Market Research LLP: Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease ...

According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected ...

XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying ...